Samchundang Pharmaceutical Stocks Crash 86% from Peak After FDA Response Surge
Samchundang Pharmaceutical's stock fell 29.87% to 167,600 won on May 21 in the Kosdaq market, hitting the lower trading limit one day after a 29.82% surge. The previous day's rally followed the company's announcement of receiving a Pre-ANDA response from the US Food and Drug Administration (FDA)
LucasBennett·07-21 13:15
